Beckman Laser Institute Medical and Surgical Clinic
Irvine, California, 92612, United States
NCT Number: NCT00585338
Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation.
It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal.
The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Irvine, California, 92612, United States
The researcher can determine the blanching of vascular lesions after Tandem laser with multiple 532/1064 nm laser pulses treatment.
The researcher will select one to four test sites spots for laser treatment. will be Different laser parameters can be used for each test site. The research will evaluate of the test sites at 6-12 weeks for bruising and blanching. Parameters of the test area with the greatest degree of blanching without adverse effects will be utilized for further treatment. If no test area is determined to have blanching without adverse effects, further test sites may be performed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser
Other names: Treatment of Vascular Lesions
Time frame: 6 months
Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser
University of California, Irvine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05755139
Pigmented Lesions, Vascular Lesion
Austin, Texas, United States
View Trial DetailsNCT04993066
Acne, Acne Vulgaris
Marlborough, Massachusetts, United States
View Trial DetailsNCT06230731
Vascular Lesion
Chicago, Illinois, United States
View Trial DetailsNCT07012668
Neuro-co-cardiological Diseases, Post-cardiac Surgery Cerebrovascular Diseases
Beijing, China
View Trial Details